Hepatitis: all 3,372 studies
Page 19 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Metformin Therapy in HCV InfectionCompletedNCT02972723Phase 4
- G-CSF Plus NAC In Severe Alcoholic HepatitisStatus unknownNCT02971306Phase 4
- Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted PatientsCompletedNCT02969668
- A Study of Lonafarnib With or Without Ritonavir in Patients With HDVWithdrawnNCT02968641Phase 2
- Efficacy and Safety of DA-2802 in Chronic Hepatitis B PatientsCompletedNCT02967939Phase 3
- A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBVStatus unknownNCT02966964Phase 2
- The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis BStatus unknownNCT02965859Phase 2
- Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing WorldCompletedNCT02964091Phase 4
- Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in FranceStatus unknownNCT02959684
- TAF Switch Study in Hepatitis B MonoinfectionStatus unknownNCT02957994Phase 4
- Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in KoreaCompletedNCT02951364
- Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Status unknownNCT02950870Phase 4
- Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune HepatitisCompletedNCT02950077Not applicable
- Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02945956Phase 4
- Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2CompletedNCT02945228
- Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of LifeCompletedNCT02943330
- Tenofovir As Prevention Of Hepatitis b Mother-to-child TransmissionStatus unknownNCT02937779Phase 4
- Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap SyndromeStatus unknownNCT02936596Not applicable
- sCD163 in PBC Patients - Assessment of Disease Severity and PrognosisActive, not recruitingNCT02924701
- A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male VolunteersCompletedNCT02920931Phase 1
- Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or CuredCompletedNCT02909023
- HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownNCT02908763Phase 4
- A Study in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT02908191Phase 1
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaCompletedNCT02907996
- Epidemiology of Viral Hepatitis Among Subjects in PrecariousCompletedNCT02907905Not applicable
- Immune Monitoring of Hepatitis C Under DAA TherapyStatus unknownNCT02904603
- A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High RiskStatus unknownNCT02901418
- Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune HepatitisStatus unknownNCT02900443Phase 4
- Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B VirusStatus unknownNCT02899130Not applicable
- Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in ChinaCompletedNCT02898922Phase 4
- Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected PatientsStatus unknownNCT02897596Phase 3
- A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAsStatus unknownNCT02894918Phase 4
- The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownNCT02893124Phase 4
- French HIV-HBV CohortStatus unknownNCT02889094
- Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB InfectionStatus unknownNCT02886182
- Ribavirin Bioavailability After Telaprevir ExposureCompletedNCT02881034
- Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune HepatitisWithdrawnNCT02878863Phase 3
- Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple TherapyCompletedNCT02877199
- A Long Term Follow-up Study of Patients From the REP 301 ProtocolCompletedNCT02876419
- Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune HepatitisStatus unknownNCT02874586Not applicable
- Regression of Liver Fibrosis After Daclatasvir and Asunaprevir TreatmentStatus unknownNCT02865369
- A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal ImpairmentCompletedNCT02864199Phase 4
- ADRENAL FUNCTION IN PATIENTS WITH ACUTE HEPATITISCompletedNCT02859584Not applicable
- Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia VasculitisStatus unknownNCT02856243
- APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and RibavirinCompletedNCT02850289
- Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)CompletedNCT02847507
- The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).Active, not recruitingNCT02845401Not applicable
- The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02838810Phase 4
- Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV InfectionCompletedNCT02836925Phase 2
- A Follow-up Evaluation Study of PRI-724-1101CompletedNCT02828254
- Investigative Mathematical Modeling of Hospital Transmission of Hepatitis CStatus unknownNCT02826447
- EFFORT Further Extension StudyStatus unknownNCT02826070Phase 4
- A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedNCT02826018Phase 1
- Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) AdultsStatus unknownNCT02822547Phase 4
- Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
- Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence StudyStatus unknownNCT02809885Not applicable
- Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic HepatitisCompletedNCT02808663Not applicable
- Liver Injury by Statins in Patients With History of Hepatitis B Virus InfectionStatus unknownNCT02808299
- Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)WithdrawnNCT02806362Phase 3
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 TabletStatus unknownNCT02805738Phase 3
- Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without InterferonCompletedNCT02804386Phase 4
- Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology ConsortiumCompletedNCT02799355
- Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?Status unknownNCT02799316Not applicable
- Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Nile Delta of EgyptStatus unknownNCT02797782
- Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic HepatitisCompletedNCT02796469
- Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive PatientsStatus unknownNCT02793791Not applicable
- Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesCompletedNCT02792088Phase 3
- Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue TherapyCompletedNCT02791386
- Association of Vitamin D Binding Protein Polymorphisms With Response to HCV TherapyCompletedNCT02788682
- Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected IndividualsCompletedNCT02786758
- Hepatocellular Carcinoma in HIV-infected PatientsCompletedNCT02785835
- Swiss HCVree TrialCompletedNCT02785666Phase 3
- Dynamic Liver Tests in Liver DiseaseCompletedNCT02782247
- Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777814Phase 2
- Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777801Phase 2
- Pegfilgrastim in Patients With Alcoholic HepatitisCompletedNCT02776059Phase 2
- Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis BStatus unknownNCT02774837Phase 4
- Study to Describe the Actual Situation of Hepatitis C Treatment in BrazilCompletedNCT02773394
- Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4Status unknownNCT02772744
- A Peer-based Mobile-health Intervention to Increase Access & Adherence to Hepatitis C Treatment & HIV Viral SuppressionCompletedNCT02772328Not applicable
- Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)CompletedNCT02768961Phase 4
- Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)Status unknownNCT02768545Phase 4
- Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort StudyCompletedNCT02766933
- Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the NeonatesStatus unknownNCT02764671Phase 4
- A Study of CDI-31244: A Novel NNI in HV and HCV Infected SubjectsCompletedNCT02760758Phase 1
- Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian AmericansCompletedNCT02760537Not applicable
- Extrahepatic Insulin Resistance in Chronic Hepatitis CCompletedNCT02760355Not applicable
- Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.CompletedNCT02759991Phase 4
- Impact of Antiviral Therapy on Gastroesophageal Varices.CompletedNCT02758509
- Counseling and Reminders for Regular HIV and STIs ScreeningCompletedNCT02752152Not applicable
- A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBVCompletedNCT02751996Phase 2
- Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)CompletedNCT02749864
- The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02745704Phase 4
- Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)Status unknownNCT02745132Phase 4
- Evaluation of HepCure Toolkit to Improve Harvoni AdherenceCompletedNCT02740556Not applicable
- Off Treatment Durability in Chronic Hepatitis B With Good Immune ControlCompletedNCT02738554Not applicable
- Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in BloodCompletedNCT02718573
- A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus InfectionCompletedNCT02716428Phase 2
- SR-BI and Antiviral Treatment Response in HCVCompletedNCT02714712